未登录 分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
Prognostic value of measurable residual disease (MRD) for venetoclax in combination with hypomethylating agents in patients diagnosed with acute myeloid leukemia: validation of the ELN-2021 MRD recommendations 可测量残留病灶(MRD)对维奈克拉与表观遗传学药物联合治疗急性髓系白血病患者的预后价值:ELN-2021 MRD建议的验证 Jimenez-Vicente, Carlos; Cardus, Aina; Castano-Diez, Sandra; Ramil, Guillermo; Garcia-Avila, Sara; Gomez-Perez, Lucia; Esteban, Daniel; Arribas, Iago; Sturla, Antonella Lucia; Lopez-Guerra, Monica; Martinez-Roca, Alexandra; Cortes-Bullich, Albert; Perez-Valencia, Amanda Isabel; Zugasti, Ines; Monge, Ines; Carcelero, Esther; Vall-Llovera, Ferran; Vives, Susana; Sierra, Jorge; Nomdedeu, Josep; Onate, Guadalupe; Garrido, Ana; Pratcorona, Marta; Pomares, Helena; Arnan, Montserrat; Guijarro, Francesca; Diaz-Beya, Marina; Esteve, Jordi 分享 收藏
HSP-CAR30 with a high proportion of less-differentiated T cells promotes durable responses in refractory CD30+lymphoma HSP-CAR30含有高比例的未分化T细胞,可促进难治性CD30+淋巴瘤的持久应答。 Caballero, Ana Carolina; Ujaldon-Miro, Cristina; Pujol-Fernandez, Paula; Montserrat-Torres, Rosanna; Guardiola-Perello, Maria; Escudero-Lopez, Eva; Garcia-Cadenas, Irene; Esquirol, Albert; Martino, Rodrigo; Jara-Bustamante, Paola; Ezquerra, Pol; Soria, Jose Manuel; Iranzo, Eva; Moreno-Martinez, Maria-Estela; Riba, Mireia; Sierra, Jorge; Alvarez-Fernandez, Carmen; Escriba-Garcia, Laura; Briones, Javier 分享 收藏
Prognostic Value of the Measurable Residual Disease (MRD) in AML Treatment with Venetoclax in Combination with Hypomethylating Agents: Validation of the ELN 2021 MRD Recommendations 可测量残留病灶(MRD)在联合维奈克拉和表观遗传学抑制剂治疗的AML治疗中的预后价值:ELN 2021年MRD建议的验证 Jimenez-Vicente, Carlos; Cardus, Aina; Lopez, Guillermo Ramil; Onate, Guadalupe; Arribas, Iago; Garcia-Avila, Sara; Gomez-Perez, Lucia; Esteban, Daniel; Sturla, Antonella; Guijarro, Francesca; Lopez-Guerra, Monica; Castano-Diez, Sandra; Martinez-Roca, Alexandra; Cortes-Bullich, Albert; Perez, Amanda Isabel; Zugasti, Ines; Monge-Escartin, Ines; Sierra, Jorge; Vives, Susana; Pomares, Helena; Arnan, Montserrat; Nomdedeu, Josep; Garrido, Ana; Pratcorona, Marta; Diaz-Beya, Marina; Esteve, Jordi 分享 收藏
10 Year Follow-up of CALGB 10603/Ratify: Midostaurin Versus Placebo Plus Intensive Chemotherapy in Newly Diagnosed FLT3 Mutant Acute Myeloid Leukemia Patients Aged 18-60 Years 10年随访研究:CALGB 10603/Ratify试验中,年龄18-60岁新诊断FLT3突变急性髓系白血病患者的米哚妥林与安慰剂联合强化化疗的比较 Stone, Richard M.; Yin, Jun; Mandrekar, Sumithra J.; Benner, Axel; Saadati, Maral; Galinsky, Ilene A.; Sanford, Ben L.; Teske, Rebecca; Geyer, Susan M.; Prior, Thomas; Amadori, Sergio; Appelbaum, Frederick R.; Brandwein, Joseph; Dohner, Konstanze; Ehninger, Gerhard; Ganser, Arnold; Klisovic, Rebecca B.; Krauter, Jurgen; Marcucci, Guido; Medeiros, Bruno; Niederwieser, Dietger W.; Sanz, Miguel A.; Schlenk, Richard F.; Serve, Hubert; Sierra, Jorge; Tallman, Martin S.; Wei, Andrew H.; Witte, Theo J. M. de; Thiede, Christian; Doehner, Hartmut; Larson, Richard A. 分享 收藏
Comparative Analysis of NGS and Digital PCR for Measurable Residual Disease Monitoring in Intensively Treated Acute Myeloid Leukemia Patients NGS与数字PCR在强化治疗急性髓系白血病患者可测量残留疾病监测中的比较分析 Lopez, Guillermo Ramil; Baleri, Alicia Artigas; Vilalta, Anna Gine; Onate, Guadalupe; Castellet, Helena; Diaz-Beya, Marina; Tormo, Mar; Cervera, Marta; Coll, Rosa; Serra, Jorge Jose Martinez; Vives, Susana; Garcia, Antonio; Riera, Martin Mascaro; Garcia, Sara; Calmet, Ferran Vall-Llovera; Arnan, Montserrat; Salamero, Olga; Diaz, Ana Garrido; Reyner, Jordi Esteve; Guinot, Josep F. Nomdedeu; Sierra, Jorge; Pratcorona, Marta 分享 收藏
分享 收藏
Comparison of Three Graft-versus-Host Disease Prophylaxis Strategies after T Cell-Replete Haploidentical Hematopoietic Transplantation: Tacrolimus versus Calcineurin Inhibitors plus Mycophenolate Mofetil versus Sirolimus plus Mycophenolate Mofetil Esquirol, Albert; Pascual, Maria Jesus; Montoro, Juan; Pinana, Jose Luis; Ferra, Christelle; Herruzo, Beatriz; Garcia-Cadenas, Irene; Balaguer, Aitana; Perez, Ariadna; Huguet, Maria; Redondo, Sara; Villalba, Marta; Hernandez-Boluda, Juan Carlos; Chorao, Pedro; Hernani, Rafael; Sanz, Jaime; Solano, Carlos; Sierra, Jorge; Martino, Rodrigo 分享 收藏
Risk scores predicting disease progression in early-stage CLL: Comparative analysis and usefulness of IGHV subset #2 to improve their accuracy 预测早期CLL疾病进展的风险评分: IGHV子集 #2的比较分析和有用性,以提高其准确性 Arguello-Tomas, Miguel; Mozas, Pablo; Albiol, Nil; Lopez-Esteban, Miguel; Sierra, Jorge; Nomdedeu, Josep; Martinez-Laperche, Carolina; Moga, Esther; Pineyroa, Juan A.; Delgado, Julio; Osorio, Santiago; Moreno, Carol 分享 收藏
Outcome improvement over time in reduced intensity conditioning hematopoietic transplantation: a 20-year experience Esquirol, Albert; Cadenas, Irene Garcia; Novelli, Silvana; Garrido, Ana; Caballero, Ana Carolina; Onate, Guadalupe; Lopez, Jordi; Redondo, Sara; Arguello, Miguel; Saavedra, Silvana; Moreno, Carolina; Briones, Javier; Sierra, Jorge; Martino, Rodrigo 分享 收藏
Midostaurin plus daunorubicin or idarubicin for young and older adults with FLT3-mutated AML: a phase 3b trial Sierra, Jorge; Montesinos, Pau; Thomas, Xavier; Griskevicius, Laimonas; Cluzeau, Thomas; Caillot, Denis; Legrand, Ollivier; Minotti, Clara; Luppi, Mario; Farkas, Firas; Bengoudifa, Bourras-Rezki; Gilotti, Geralyn; Hodzic, Sejla; Rambaldi, Alessandro; Venditti, Adriano 分享 收藏
Successful Outcome in Patients with Myelofibrosis Undergoing Allogeneic Donor Hematopoietic Cell Transplantation Using Reduced Doses of Post-Transplantation Cyclophosphamide: Challenges and Review of the Literature 骨髓纤维化患者接受异基因供体造血细胞移植后使用减量环磷酰胺的成功结果: 挑战和文献综述 Garcia-Cadenas, Irene; Redondo, Sara; Esquirol, Albert; Portos, J. M.; Novelli, Silvana; Saavedra, Silvana; Moreno, Carol; Garrido, Ana; Onate, Guadalupe; Lopez, Jordi; Caballero, Ana-Carolina; Miqueleiz, Sara; Arguello-Tomas, Miguel; Briones, Javier; Sierra, Jorge; Martino, Rodrigo 分享 收藏
Feasibility of a New Model of Care for Allogeneic Stem Cell Transplantation Recipients Facilitated by eHealth: The MY-Medula Pilot Study Redondo, Sara; De Dios, Anna; Gomis-Pastor, Mar; Esquirol, Albert; Aso, Olga; Triquell, Merce; Moreno, M. E.; Riba, Mireia; Ruiz, Julia; Blasco, Alex; Tobajas, Eva; Gonzalez, Iria; Sierra, Jorge; Martino, Rodrigo; Garcia-Cadenas, Irene 分享 收藏
Survival improvement of patients with FLT3 mutated acute myeloid leukemia: results from a prospective 9 years cohort Onate, Guadalupe; Pratcorona, Marta; Garrido, Ana; Artigas-Baleri, Alicia; Bataller, Alex; Tormo, Mar; Arnan, Montserrat; Vives, Susana; Coll, Rosa; Salamero, Olga; Vall-Llovera, Ferran; Sampol, Antonia; Garcia, Antoni; Cervera, Marta; Avila, Sara Garcia; Bargay, Joan; Ortin, Xavier F.; Nomdedeu, Josep; Esteve, Jordi; Sierra, Jorge 分享 收藏
Outcomes in Patients with FLT3-Mutated Relapsed/Refractory Acute Myelogenous Leukemia Who Underwent Transplantation in the Phase 3 ADMIRAL Trial of Gilteritinib versus Salvage Chemotherapy 在Gilteritinib与挽救性化疗的3期ADMIRAL试验中接受移植的FLT3-Mutated复发/难治性急性骨髓性白血病患者的结局 Perl, Alexander E.; Larson, Richard A.; Podoltsev, Nikolai A.; Strickland, Stephen; Wang, Eunice S.; Atallah, Ehab; Schiller, GaryJ.; Martinelli, Giovanni; Neubauer, Andreas; Sierra, Jorge; Montesinos, Pau; Recher, Christian; Yoon, Sung-Soo; Maeda, Yoshinobu; Hosono, Naoko; Onozawa, Masahiro; Kato, Takayasu; Kim, Hee-Je; Hasabou, Nahla; Nuthethi, Rishita; Tiu, Ramon; Levis, Mark J. 分享 收藏
T22-PE24-H6 Nanotoxin Selectively Kills CXCR4-High Expressing AML Patient Cells In Vitro and Potently Blocks Dissemination In Vivo Nunez, Yaiza; Garcia-Leon, Annabel; Falgas, Aida; Serna, Naroa; Sanchez-Garcia, Laura; Garrido, Ana; Sierra, Jorge; Gallardo, Alberto; Unzueta, Ugutz; Vazquez, Esther; Villaverde, Antonio; Mangues, Ramon; Casanova, Isolda 分享 收藏